Understanding Prostate Cancer - Intermediate Risk
Dr. Larry Goldenberg, Professor & Head, Department of Urologic Sciences, and Director of Development, the Vancouver Prostate Centre, discusses Intermediate Risk Prostate Cancer treatments.
▶︎
Surgery or Radiotherapy for Prostate Cancer? Here's What the Evidence Shows
▶︎
4 weeks post Prostatectomy
▶︎
Active Surveillance for Prostate Cancer, Dr. Christopher Saigal | UCLAMDChat
▶︎
High-risk prostate cancer: what patients and physicians should know in 2026
▶︎
Many Men Chose The Wrong Prostate Cancer Treatment: Here’s Why
▶︎
Best Ways to Prevent Prostate Enlargement, Explained by a Urologist
▶︎
NanoKnife / Prostate Cancer Webinar with Dr. Carl Capelouto
▶︎
Optimal Duration of Hormone Therapy For #ProstateCancer | #MarkScholzMD #AlexScholz #PCRI
▶︎
Prostate Cancer: What You NEED To Know
▶︎
Intermediate-Risk Prostate Cancer Treatment - MUSC Hollings
▶︎
New Study Shows The Impact of Diet on Prostate Cancer | Mark Scholz, MD | PCRI
▶︎
What if I DON'T treat my low-risk prostate cancer?
▶︎
Robotic Prostate Surgery Recovery: What to Expect
▶︎
Active Surveillance: Intermediate Disease and High-Volume Grade Group 1 Prostate Cancer
▶︎
Hormonal Therapy for Prostate Cancer
▶︎
Radiation therapy for prostate cancer: the basics
▶︎
Making Decisions After Being Diagnosed with Early Stage Prostate Cancer | UCLAMDChat
▶︎
Prostate Biopsy Trap: What Most Men Aren’t Told
▶︎
Gleason 3+4 Prostate Cancer
▶︎